Market Tracker

02/22 12:27pm ET

Ionis Pharmaceuticals Inc (NASDAQ:IONS)

46.13
BATS BZX Real-Time Price
As of 12:26pm ET
 -0.07 / -0.15%
Today’s Change
19.59
Today|||52-Week Range
57.00
-3.55%
Year-to-Date
Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?
Feb 21 / Zacks.com - Paid Partner Content
3 Biotechs With Tremendously Promising Pipelines
Feb 15 / MotleyFool.com - Paid Partner Content
Did Biogen Inc. Shoot Itself in the Foot?
Feb 21 / MotleyFool.com - Paid Partner Content
Ionis Pharmaceuticals (IONS) Sees Hammer Chart Pattern: Time to Buy?
Feb 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close46.20
Today’s open46.04
Day’s range45.48 - 46.16
Volume28,034
Average volume (3 months)2,197,073
Market cap$5.6B
Dividend yield--
Data as of 12:26pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-124.24%
Earnings growth (this year)-38.29%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+32.47%
P/E ratioNM
Price/Sales26.13
Price/Book27.69

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.18+1.10%
MNKMallinckrodt Plc+0.47+0.87%
OPKOPKO Health Inc-0.10-1.16%
ACADACADIA Pharmaceutica...-0.05-0.13%
Data as of 12:27pm ET, 02/22/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$283.7M
Annual profit (last year)-$88.3M
Net profit margin-31.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts